Osteosarcoma :: IDM Pharma’s Mepact, mifamurtide – Junovan in the Treatment of Osteosarcoma

IDM Pharma (NASDAQ:IDMI) announced today that the company has submitted a Marketing Authorization Application (MAA) in eCTD format (electronic common technical document) to the European Medicines Agency (EMEA) for Mepact (mifamurtide for injection), requesting approval for its use in the treatment of patients with newly diagnosed resectable high-grade osteosarcoma following surgical resection in combination with post-operative multi-agent chemotherapy. This announcement follows the October 25, 2006 submission of a New Drug Application (NDA) for Junovan (mifamurtide for injection) to the Food and Drug Administration (FDA) in the United States.

ADHD :: Study Evaluates Two Medications for ADHD

University of Illinois at Chicago researchers are comparing two drugs commonly used to treat attention deficit hyperactivity disorder to determine if genetic factors predict which children will respond to either or both drugs.

Health :: Water – More Valuable than Diamonds

A new study by University of Arkansas economists shows a strong relationship between economic freedom and access to water. David Gay and Charles Britton, economics professors in the Sam M. Walton College of Business, and Richard Ford, professor of economics at the University of Arkansas at Little Rock, compared data from two important international indices and found that greater economic freedom leads to economic development, which in turn decreases the amount of poverty associated with a nation’s lack of access to water.

Health Care :: Allied Health Professions Week Highlights Workforce Shortage Crisis

The first baby boomers are turning 60 this year. Some question whether there will be enough health care professionals to take care of them. An aging society and increased cases of chronic conditions like diabetes and obesity are straining an already fragile health care workforce. Now, the University of Missouri-Columbia is looking at ways to write a prescription for one of the major ailments facing today?s society, according to Richard Oliver, dean of the MU School of Health Professions. MU recently spearheaded the creation of FuturePoint Summit, a national coalition of academic and business leaders in the health care field, to find solutions for the allied health workforce shortage.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack